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Abstract
Background: Oral cancer, which is the fourth most common cancer in Taiwanese men, is associated with environmental
carcinogens. The possibility that genetic predisposition in nuclear factor-kappa B (NF-kB)-signaling pathways activation is
linked to the development of oral squamous cell carcinoma (OSCC) requires investigation. The current study examines
associations between polymorphisms within promoter regions of NFKB1 encoding NF-kB1 and NFKBIA encoding
IkappaBalpha (IkBa) with both the susceptibility to develop OSCC and the clinicopathological characteristics of the tumors.
Methodology/Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase
chain reaction (real-time PCR) for 462 patients with oral cancer and 520 non-cancer controls. We found that NFKB1 294
ATGG1/ATGG2, 294 ATGG2/ATGG2, and the combination of 294 ATGG1/ATGG2 and ATGG2/ATGG2 genotypes NFKBIA
2826 T (CT+TT) and 2881 G (AG+GG) allelic carriages, were more prevalent in OSCC patients than in non-cancer
participants. Moreover, we found that NFKB1 or NFKBIA gene polymorphisms seem to be related to susceptibility to develop
oral cancer linked to betel nut and tobacco consumption. Finally, patients with oral cancer who had at least one 2519 T
allele of the NFKBIA gene were at higher risk for developing distant metastasis (P,.05), compared with those patients CC
homozygotes.
Conclusions: Our results suggest that NFKB1 294 ATTG2, NFKBIA 2826 T, and 2881 G alleles are associated with oral
carcinogenesis. The combination of NFKB1 or NFKBIA gene polymorphisms and environmental carcinogens appears related
to an increased risk of oral cancer. More importantly, the genetic polymorphism of NFKBIA 2519 might be a predictive
factor for the distal metastasis of OSCC in Taiwanese.
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Introduction
Oral squamous cell carcinoma (OSCC), a common malignant
cancer of the head and neck region, is the fourth most common
cancer among men and the sixth leading cause of cancer deaths in
Taiwan[1].OSCCdevelopmentisamultistep processrequiringthe
accumulation of multiple genetic alterations, influenced by a
patient’s genetic predisposition and by environmental factors. The
environmental factors include alcohol and tobacco consumption,
betel (areca) quid chewing, chronic inflammation, and viral
infection [1–6]. Gene expression is affected by a single-nucleotide
polymorphism (SNP) located within the promoter or other
regulatory regions of the gene and are thought to be associated
with the development of certain diseases [7]. To elucidate the
complex process of carcinogenesis and improve the scientific basis
for preventive interventions, the identification of major genes
influencing a patient’s susceptibility to OSCC should be prioritized.
Activation of nuclear factor-kappa B (NF-kB), a hallmark of the
inflammatory response, is detected frequently in tumors and may
play an important role in linking inflammation to tumor
development and progression [8,9]. NF-kB was originally
identified as a nuclear factor specific to B cells bound to the B
site of the k-light chain gene enhancer. NF-kB is a heterodimer in
the Rel family, which contains 5 members: RelA, RelB, c-Rel,
p50/105 (NF-kB1), and p52/p100; the dimeric form of NF-kB
p50/RelA is the most common form. NF-kB plays a central role in
coordinating the expression of a wide variety of genes that control
innate and adaptive immune responses, and also plays a critical
role in cancer development and progression [8]. In normal cells,
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IkB. When IkB proteins are phosphorylated and degraded, NF-kB
is released and further translocated to the nucleus, where gene
transcription is initiated [10].
The IkB family includes IkappaB alpha (IkBa), IkBb,I kBc,
IkBd,I kBe,I kB-f,I kB-R, Bcl-3, p100, and p105, which are all
constitutively expressed except for IkBa, which is inducibly
expressed. IkBa is a classic form of the IkB family that can be
found in the cytoplasm and nuclei [11]. Previous studies
demonstrated that NF-kB suppression in cancer inhibits cell
proliferation, causes cell-cycle arrest, and results in apoptosis,
suggesting that NF-kB plays an important role in cell proliferation
and survival [12]. Furthermore, NF-kB is known to prevent
apoptosis by inducing antiapoptotic proteins, and suppresses the
apoptotic potential of chemotherapeutic agents, leading to
chemoresistance [13]. Aberrant expression of NF-kB proteins
has been well documented in several types of cancer, including
OSCC [14], with the level increasing gradually from premalignant
lesions to invasive cancer [15]. Moreover, NF-kB1, which
comprises p50 homodimers, transcriptionally regulates the anti-
apoptotic protein Bcl-2, which is overexpressed in a high
proportion of oral cancer cases [16]. These various findings
suggest that NF-kB signaling plays an important role in oral
carcinogenesis.
Prior research has reported that polymorphic variations in
promoter regions of the NF-kB1 gene NFKB1 and the IkBa gene
NFKBIA and in the 39-untranslated region (39-UTR) of NFKBIA
were associated with a risk for Hodgkin’s lymphoma, multiple
myeloma, breast cancer, prostate cancer, gastric cancer, colorectal
cancer, and melanoma [17–23]. In Taiwan Lin et al. investigated
the 294 ins/del ATTG polymorphism in the NFKB1 promoter
among 3 population groups, namely, OSCC patients, male areca
chewers with oral submucous fibrosis, and controls (non-areca
chewers). They found no significant difference in NFKB1
genotypes among the 3 groups [24]. However, after stratification
by age, OSCC was shown to have a higher frequency of the
insertion allelotype in patients older than 50 years. No significant
difference was found for the NFKB1 allelotype or genotype in
patients with OSCC who exhibited different statuses of lymph
node metastasis or clinical stage. Apart from the Lin et al. study,
no reports have focused on the association between NFKB1 and
NFKBIA polymorphisms and OSCC development.
The current study investigated relationships between SNPs in
the promoter regions of the NFKB1 and NFKBIA genes and the risk
of oral cancer. In addition, we evaluated the influences of these
SNPs combined with betel nut and tobacco consumption, which
lead to the susceptibility of oral cancer. We also investigated the
relationship among genetic influences, environmental exposure,
and the clinicopathological characteristics of oral cancer. To our
knowledge, this is the first study to demonstrate a significant
association between NFKB1 and NFKBIA polymorphisms and oral
carcinogenesis.
Materials and Methods
Subjects and specimen collection
We recruited 462 patients (444 men and 18 women, with a
mean age of 54.4611.4 years) at Chung Shan Medical University
Hospital in Taichung and Changhua Christian Hospital and Show
Chwan Memorial Hospital in Changhua, Taiwan. Patients were
enrolled as a case group between 2007 and 2011. For the control
group, we randomly chose 520 non-cancer people (426 men and
94 women, with a mean age of 52.4614.7 years) who visited the
same hospitals and resided in the same geographic area. Before
commencement of the study, approval was obtained from the
Institutional Review Board of Show Chwan Memorial Hospital,
and each person provided written informed consent to participate
in the study.
For both cases and controls, we used a questionnaire to obtain
information on patient exposure to betel quid chewing, tobacco
use, and alcohol consumption. Medical information for the cases
was obtained from their medical records, and included TMN
clinical staging, primary tumor size, lymph node involvement, and
histologic grade. Oral cancer patients were clinically staged at the
time of diagnosis according to the TNM staging system of the
American Joint Committee on Cancer (AJCC) Staging Manual
(7
th ed.) [25]. Tumor differentiation was examined by a pathologist
according to the AJCC classification. Whole blood specimens
collected from controls and OSCC patients were placed in tubes
containing ethylenediaminetetraacetic acid (EDTA), and were
immediately centrifuged and stored at 280uC.
Genomic DNA Extraction
Genomic DNA was extracted using QIAamp DNA blood mini
kits (Qiagen, Valencia, CA, USA) following the manufacturer’s
instructions. We dissolved DNA in a TE buffer (10 mM Tris, 1 mM
EDTA; pH 7.8), which was subsequently quantified by measuring
the OD260. The final preparation was stored at 220uC and used to
create templates for the polymerase chain reaction (PCR).
Real-time PCR
The allelic discrimination of the NFKB1 294 ATTG, NFKBIA
2519, NFKBIA 2826, and NFKBIA 2881 gene polymorphisms
were assessed with the ABI StepOne
TM Real-Time PCR System
(Applied Biosystems) and analyzed with SDS v3.0 software
(Applied Biosystems) using the TaqMan assay. The final volume
for each reaction was 5 mL, containing 2.5 mL TaqMan
Genotyping Master Mix, 0.125 mL TaqMan probes mix, and
10 ng genomic DNA. The real-time PCR included an initial
denaturation step at 95uC for 10 min, followed by 40 cycles at of
95uC for 15 s and then at 60uC for 1 min.
Statistical analysis
Differences between the 2 groups were considered significant if
p-values were less than .05. Hardy-Weinberg equilibrium (HWE)
was assessed using a goodness-of-fit X
2-test for biallelic markers.
The Mann-Whitney U-test and Fisher’s exact test were used to
compare differences in the distributions of patient demographic
characteristics between the non-cancer (control) and oral cancer
groups. The adjusted odds ratios (ORs) and 95% confidence
intervals (CIs) of the association between genotype frequencies and
risk in addition to clinicopathological characteristics were
estimated using multiple logistic regression models, after control-
ling for other covariates. We analyzed all data using the Statistical
Analytic System (SAS Institute, Cary, NC, USA) software (v. 9.1,
2005) for Windows.
Results
The statistical analysis of demographic characteristics is shown
in Table 1. We found significantly different distributions of age
(p=0.023), sex (p,0.001), betel quid chewing (p,0.001), alcohol
consumption (p,0.001), and tobacco use (p,0.001) between
control participants and OSCC patients. To reduce the possible
interference of environmental factors, the adjusted ORs (AORs)
with 95% CIs were estimated by multiple logistic regression
models after controlling for other covariates in each comparison.
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(p.0.05). The data in Table 2 show that, for both OSCC patients
and the controls, alleles with the highest distribution frequency
were as follows: heterozygous ATGG1/ATGG2 for the 294 locus
of the NFKB1 gene; and homozygous C/C, C/C, and AA,
respectively, for 2519, 2826, and 2881 loci of the NFKBIA gene.
According to the AORs (95% CI), significantly (p,0.05) higher
risks for OSCC were noted for NFKB1 gene polymorphisms 294
ATGG1/ATGG2,294 ATGG2/ATGG2, and the combination
of 294 ATGG1/ATGG2 and ATGG2/ATGG2 genotypes.
Compared with the corresponding wild-type (WT) homozygotes
of the control group, the risk for OSCC was 1.8-fold (95%
CI=1.2,2.8) for 294 ATGG1/ATGG2; 2.2-fold (95% CI=1.2–
4.2) for 294 ATGG2/ATGG2l; and 1.8-fold (95% CI=1.2–2.8)
for the combination of 294 ATGG1/ATGG2 and ATGG2/
ATGG2. These results were obtained after adjusting for age, sex,
betel quid chewing, alcohol consumption, and tobacco use.
We also compared the results from participants with the
polymorphic gene to those from participants showing the WT
gene. We found significantly higher risks for OSCC in participants
with the NFKBIA 2826 C/T, 2826 C/T+T/T, 2881 A/G, and
2881 A/G+GG polymorphic genotypes. These risks were,
respectively, 1.6-fold (95% CI=1.0–2.6), 1.7-fold (95%
CI=1.1–2.7), 1.6-fold (95% CI=1.0–2.6), and 1.7-fold (95%
CI=1.2–2.7), compared with the WT. However, people with the
NFKBIA 2519 polymorphic gene were not at a significantly higher
risk than those with the WT gene.
Interactive effects between environmental risk factors and
genetic polymorphisms of NFKB1 and NFKBIA are shown in
Tables 3 and 4. Among 598 smokers, participants with at least one
ATGG2 allele of NFKB1 294, the T allele of either NFKBIA 2519
or 2826, or the G allele of NFKBIA 2881 were at a higher risk for
OSCC if they also chewed betel nut. These increased risks were
67.3-fold (95% CI=18.9–239.4), 29.5-fold (95% CI=9.6–91.1),
45.0-fold (95% CI=14.6–138.5), and 45.0-fold (95% CI=14.6–
138.5), respectively. Similarly, compared with people who had
WT homozygotes but did not chew betel nut, people who chewed
betel nut and had any one of these polymorphisms were at higher
risk for OSCC development. These increased risks were as follows:
6.9-fold (95% CI=2.5–18.9) for the ATGG2 allele of NFKB1
294; 14.2-fold (95% CI=8.3–24.5) for the T allele of NFKBIA
2519; 12.4-fold (95% CI=7.3–21.2) for the T allele of NFKBIA
2826; and 12.4-fold (95% CI=7.3–21.2) for the G allele of
NFKBIA 2881 (Table 3).
Among betel nut consumers in the cohort, tobacco smoking
elevated oral cancer risk significantly in participants polymorphic
for NFKB1 in the 294 locus or NFKBIA in three loci (2519, 2826,
and 2881), compared with people with the WT gene who did not
smoke tobacco (Table 4). Moreover, people who were either
polymorphic for NFKBIA in 3 loci (2519, 2826, and 2881) or
who smoked were at 4.67- to 5.91-fold risk (p,0.05) of developing
oral cancer, compared with people with the WT gene who did not
smoke (Table 4). These results suggest that NFKB1 and NFKBIA
gene polymorphisms exert a strong influence on oral cancer
susceptibility in men who chew betel nut and/or smoke tobacco.
To explore the effects of polymorphic genotypes of NFKB1 and
NFKBIA on the clinical status of OSCC, we classified OSCC
patients into 2 subgroups. In the first subgroup, patients had
homozygous WT alleles, and in the second subgroup, they had at
least one polymorphic allele. For the genotypic frequencies of the
SNPs, only NFKBIA 2519 showed a significant association with
clinical pathological variables in OSCC patients. Compared with
the WT genotype (C/C), patients with at least one polymorphic T
allele of NFKBIA 2519 showed a higher risk (4.88-fold; 95%
CI=1.2–20.4) for distant metastasis (Table 5).
Discussion
The NF-kB pathway plays an important role in tumor
development and aggressiveness by enhancing tumor angiogenesis,
antiapoptosis, and proliferation, and by repressing the immune
response [12,26]. NF-kB is rarely found to be constitutively active
in normal cells, but it is constitutively active in most tumor cell
lines [27–29]. Prior research has demonstrated that NF-kBi s
constitutively activated in OSCC [15]. Furthermore, the 294
insertion/deletion ATTG polymorphism was shown to have a
regulatory influence on NFKB1 gene expression; the promoter
sequence containing the ATTG2 allele displayed a 26 higher
activity than comparable sequences containing the ATTG1 allele
[30]. The allele plays an important role in susceptibility to prostate
cancer, cervical squamous cell carcinoma, gastric cancer, and
hepatocellular carcinoma [22,23,31,32]. Thus, increased risk for
oral cancer associated with the NFKB1 ATGG1/ATGG2 variant
might have resulted from its positive regulation of NF-kB
expression (Table 2).
Alcohol consumption, tobacco smoking, and betel quid chewing
are the main known etiologic factors of oral cancer. In this study,
we observed that higher ratios of people in the OSCC group had
consumed alcohol and tobacco and chewed betel quid (61.7%,
84.0%, and 76.4%, respectively), compared with the controls
(40.3%, 40.4%, and 17.5%, respectively) (Table 1). This finding
indicated that alcohol and tobacco consumption and betel quid
chewing are highly associated with increased risks for oral cancer.
Long-term tobacco smoking and betel nut chewing have been
shown to contribute to carcinogenesis [3–5,33]. Betel nut
constituents can increase protein levels of c-fos and c-jun proto-
oncogenes, and tobacco consumption can significantly increase
nuclear hypoxia-inducible factor (HIF)-1a expression in oral
cancer [34,35].
People carrying the murine double minute 2 (MDM2) SNP 309 GG
genotype have oral mucosa that is more susceptible to environ-
Table 1. Distributions of demographic characteristics in 520
controls and 462 patients with oral cancer.
Variable Controls (N=520)Patients (N=462)P-value
Age (y) Mean ± S.D. Mean ± S.D.
52.4614.7 54.4611.4 p=.023*
Sex n (%) n (%)
Male 426 (81.9%) 444 (96.1%)
Female 94 (18.1%) 18 (3.9%) p,.0001*
Betel nut chewing
No 429 (82.5%) 109 (23.6%)
Yes 91 (17.5%) 353 (76.4%) p,.0001*
Alcohol consumption
No 309 (59.4%) 177 (38.3%)
Yes 211 (40.3%) 285 (61.7%) p,.0001*
Tobacco consumption
No 310 (59.6%) 74 (16.0%)
Yes 210 (40.4%) 388 (84.0%) p,.0001*
Mann-Whitney U test or Fisher’s exact test were used to analyze differences
between controls and patients with oral cancer.
*indicates statistical significance at p,0.05.
doi:10.1371/journal.pone.0035078.t001
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Variable Controls (N=520) n (%) Patients (N=462) n (%) OR (95% CI) AOR (95% CI)
NFkB1
Del/Del 168 (32.3%) 100 (21.6%) 1.0 1.0
Del/Ins 271 (52.1%) 246 (53.3%) 1.5 (1.1–2.1) 1.8 (1.1–2.7)
Ins/Ins 81 (15.6%) 116 (25.1%) 1.5 (1.1–2.1) 2.2 (1.2–4.2)
Del/Ins+Ins/Ins 352 (67.7%) 362 (78.4%) 1.7 (1.3–2.3) 1.8 (1.2–2.8)
NFKBIA 2519
CC 432 (83.1%) 381 (82.5%) 1.0 1.0
CT 86 (16.5%) 78 (16.9%) 1.0 (0.7–1.4) 1.3 (0.9–2.2)
TT 2 (0.4%) 3 (0.6%) 1.7 (0.3–10.2) 5.4 (0.4–74.1)
CT+TT 88 (16.9%) 81 (17.5%) 1.0 (0.7–1.5) 1.4 (0.9–2.2)
NFKBIA 2826
CC 438 (84.2%) 351 (76.0%) 1.0 1.0
CT 78 (15.0%) 101 (21.8%) 1.6 (1.2–2.2) 1.6 (1.0–2.6)
TT 4 (0.8%) 10 (2.2%) 3.1 (1.0–10.0) 3.4 (0.6–18.3)
CT+TT 82 (15.8%) 111 (24.0%) 1.7 (1.2–2.3) 1.7 (1.2–2.7)
NFKBIA 2881
AA 438 (84.2%) 351 (76.0%) 1.0 1.0
AG 78 (15.0%) 101 (21.8%) 1.6 (1.2–2.2) 1.6 (1.0–2.6)
GG 4 (0.8%) 10 (2.2%) 3.1 (1.0–10.0) 3.4 (0.6–18.3)
AG+GG 82 (15.8%) 111 (24.0%) 1.7 (1.2–2.3) 1.7 (1.2–2.7)
Odds ratios (ORs) and their 95% confidence intervals (CIs) were estimated by logistic regression models. The adjusted odds ratios (AORs) with 95% CIs were estimated
by multiple logistic regression models after controlling for age, sex, betel quid chewing, alcohol consumption, and tobacco use.
doi:10.1371/journal.pone.0035078.t002
Table 3. Adjusted odds ratio (AOR) and 95% CI for oral cancer associated with NFKB and NFKBIA genotypic frequencies and betel
nut chewing among 598 smokers.
Variable Controls (n=210) (%) Patients (n=388) (%) OR (95% CI) AOR (95% CI)
NFKB1
aDel/Del genotype & non-betel nut chewing 39 (18.6%) 7 (1.8%) 1.0 1.0
bDel/Ins or Ins/Ins genotype or betel nut chewing 118 (56.2%) 128 (33.0%) 6.0 (2.6–14.0) 6.9 (2.5–18.9)
cDel/Ins or Ins/Ins genotype with betel nut chewing 53 (25.2%) 253 (65.2%) 26.6 (11.3–62.7) 67.4 (18.9–239.4)
NFKBIA 2519
aCC genotype & non-betel nut chewing 119 (56.7%) 47 (12.1%) 1.0 1.0
bCT or TT genotype or betel nut chewing 81 (38.6%) 290 (74.8%) 9.1 (6.0–13.8) 14.2 (8.3–24.5)
cCT or TT genotype with betel nut chewing 10 (4.7%) 51 (13.1%) 12.9 (6.1–27.5) 29.5 (9.6–91.1)
NFKBIA 2826
aCC genotype & non-betel nut chewing 123 (58.6%) 20 (13.1%) 1.0 1.0
bCT or TT genotype or betel nut chewing 76 (36.2%) 134 (65.5%) 8.1 (5.3–12.2) 12.4 (7.3–21.2)
cCT or TT genotype with betel nut chewing 11 (5.2%) 138 (21.4%) 18.2 (9.0–37.0) 45.0 (14.6–138.5)
NFKBIA 2881
aAA genotype & non-betel nut chewing 123 (58.6%) 20 (13.1%) 1.0 1.0
bAG or GG genotype or betel nut chewing 76 (36.2%) 134 (65.5%) 8.1 (5.3–12.2) 12.4 (7.3–21.2)
cAG or GG genotype with betel nut chewing 11 (5.2%) 138 (21.4%) 18.2 (9.0–37.0) 45.0 (14.6–138.5)
ORs with 95% CIs were estimated by logistic regression models. AORs with 95% CIs were estimated by multiple logistic regression models after controlling for age and
sex.
aPeople with wild genotype but not chewers of betel nut.
bPeople with either one or more mutated genotypes, or chewers of betel nut (but not both).
cPeople with at least one mutated genotype and also chewers of betel nut.
doi:10.1371/journal.pone.0035078.t003
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[36]. Therefore, exposure to these factors can result in earlier
onset of tumor formation [36]. Accordingly, we evaluated the
combined effect of environmental carcinogens and NFKB1 gene
polymorphisms on the risk of oral cancer (Tables 2, 3). We found
that the NFKB1 294 insertion/deletion ATTG polymorphism
Table 4. Adjusted odds ratio (AOR) and 95% CI for oral cancer associated with NFKB and NFKBIA genotypic frequencies and
cigarette smoking among 444 betel nut consumers.
Variable Controls (n=91) (%) Patients (n=353) (%) OR (95% CI) AOR (95% CI)
NFKB1
aDel/Del genotype & non-smoker 8 (8.8%) 7 (2.0%) 1.0 1.0
bDel/Ins or Ins/Ins genotype or smoker 30 (33.0%) 93 (26.3%) 3.5 (1.2–10.6) 3.0 (0.7–13.8)
cDel/Ins or Ins/Ins genotype with smoking 53 (58.2%) 253 (71.7%) 5.5 (1.9–15.7) 6.9 (1.7–28.6)
NFKBIA 2519
aCC genotype & non-smoker 16 (17.6%) 18 (5.1%) 1.0 1.0
bCT or TT genotype or smoker 65 (71.4%) 284 (80.5%) 3.9 (1.9–8.0) 5.9 (2.3–15.0)
cCT or TT genotype with smoking 10 (11.0%) 51 (14.4%) 4.5 (1.7–11.8) 14.5 (2.0–106.0)
NFKBIA 2826
aCC genotype & non-smoker 15 (16.5%) 19 (5.4%) 1.0 1.0
bCT or TT genotype or smoker 65 (71.4%) 251 (71.1%) 3.0 (1.5–6.3) 4.7 (1.9–11.6)
cCT or TT genotype with smoking 11 (12.1%) 83 (23.5%) 6.0 (2.4–15.0) 13.9 (3.2–59.8)
NFKBIA 2881
aAA genotype & non-smoker 15 (16.5%) 19 (5.4%) 1.0 1.0
bAG or GG genotype or smoker 65 (71.4%) 251 (71.1%) 3.0 (1.5–6.3) 4.7 (1.9–11.6)
cAG or GG genotype with smoking 11 (12.1%) 83 (23.5%) 6.0 (2.4–15.0) 13.9 (3.2–59.8)
Odds ratios (ORs) with their 95% confidence intervals were estimated by logistic regression models.
Adjusted odds ratios (AORs) with their 95% confidence intervals were estimated by multiple logistic regression models after controlling for age and sex.
aPeople with wild genotype but not cigarette smokers.
bPeople with either one or more mutated genotypes, or smokers (but not both).
cPeople with at least one mutated genotype and also cigarette smokers.
doi:10.1371/journal.pone.0035078.t004
Table 5. Distribution frequencies for clinical status and NFKBIA2519 genotype in 462 patients with OSCC.
Variable genotypic frequencies
CC (N=381) n (%) CT+TT (N=81) n (%) OR (95% CI) AOR (95% CI)
Clinical Stage
Stage I/II 174 (45.7%) 39 (48.1%) 1.0 1.0
Stage III/IV 207 (54.3%) 42 (51.9%) 0.9 (0.6–1.5) 0.7 (0.4–1.3)
Tumor size
T2 241 (63.3%) 52 (64.2%) 1.0 1.0
.T2 140 (36.7%) 29 (35.8%) 1.0 (0.6–1.6) 0.7 (0.4–1.3)
Lymph node metastasis
No 246 (64.6%) 52 (64.2%) 1.0 1.0
Yes 135 (35.4%) 29 (35.8%) 1.0 (0.6–1.7) 1.1 (0.6–1.9)
Distant metastasis
No 377 (99.0%) 77 (95.1%) 1.0 1.0
Yes 4 (1.0%) 4 (4.9%) 4.9 (1.2–20.0)* 4.9 (1.2–20.4)*
Cell differentiation
Well differentiated 56 (14.7%) 12 (18.8%) 1.0 1.0
Moderately or poorly differentiated 325 (85.3%) 69 (85.2%) 1.0 (0.5–1.9) 1.1 (0.5–2.4)
ORs with 95% CIs were estimated by logistic regression models.
AORs with 95% CIs were estimated by multiple logistic regression models after controlling for sex, betel quid chewing, alcohol consumption, and tobacco consumption.
.T2: tumor size .2 cm in the greatest dimension.
*indicates statistical significance at p,0.05.
doi:10.1371/journal.pone.0035078.t005
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risk of oral carcinogenesis. This phenomenon might be caused by
alterations in the binding affinities between betel nut and tobacco
constituents and the promoter of the polymorphic NFKB1 gene.
Consequently, expression or activity of NF-kB was further
changed. Several earlier reports have indicated that tobacco and
betel nut constituents can induce NF-kB activation in oral
keratinocytes [37,38]. Moreover, evidence has shown that alkaline
saliva generated by chewing betel quid may play a role in
cigarette-related nicotine-induced DNA damage, and reactive
oxygen species may be involved in generating this DNA damage
[39]. These findings provide a possible molecular explanation for
the synergistic effect of betel quid chewing and smoking in oral
cancer development. However, details underlying the mechanism
must be verified by other well-designed experiments.
An imbalance between NF-kB and IkB is a critical step in
tumor development and response to treatment [40]. Polymor-
phisms of the 3 loci (2519, 2826, and 2881) of the NFKBIA
promoter were investigated in this study. The 2881 position was
selected based on potential functional effects because of its location
within the transcription factor, retinoic acid-related orphan
receptor a (RORa), and binding sites [41]. NFKBIA 2881G
might alter the binding ability of RORa, which plays a potential
role in cancer development [41]. Moreover, 2881 and 2826 in
the NFKBIA promoter showed strong local linkage disequilibrium
(LD) in 2 Asian populations (Chinese and Japanese). The current
study findings showed that Taiwanese men with at least one
polymorphic G allele of NFKBIA 2881 or the T allele of NFKBIA
2826 are at a high risk for oral carcinogenesis (Table 2). The
synergistic effect of environmental factors (betel quid and smoking)
and NFKBIA 2881 and 2826 polymorphisms on the risk of oral
cancer was also demonstrated adequately (Tables 3 and 4).
Although to date no direct evidence has been presented proving
that 2881G or 2826T at the promoter of NFKBIA decreases
promoter activity, indirect evidence indicates this possibility. For
instance, NF-kB expression was twice as high in patients with
sarcoidosis, compared with that of control participants. In
contrast, the 2881G and 2826T allelic carriages were more
prevalent in sarcoidosis patients than in controls [42], indicating
that the 2881G and 2826T allelic carriages might be associated
with increased activity of NF-kB. Because IkBa is an absolute
requirement for normal termination of the NF-kB response [11],
NFKBIA 2881G and 2826T allelic carriages were thought to
retard efficient IkBa expression.
In conclusion, our results suggest that NFKB1 gene polymor-
phisms might be correlated with oral cancer susceptibility, and the
combined effect of NFKB1 or NFKBIA gene polymorphisms with
environmental carcinogens increases risk of oral cancer develop-
ment significantly. Patients with oral cancer carrying at least one T
allele of NFKBIA 2519 are at higher risk of developing distal
metastasis, compared with patients carrying C/C homozygotes.
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